Market Closed -
Other stock markets
|
Pre-market 05:57:41 pm | |||
151 USD | +1.19% |
|
151.5 | +0.34% |
01:27pm | Genmab, J&J Log Higher Q2 Sales for Blood Cancer Drug Darzalex | MT |
01:26pm | Stock Futures Decline as Traders Await More Earnings; Asia, Europe Churn | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.66% | 36TCr | |
+61.53% | 85TCr | |
+32.85% | 63TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+13.36% | 24TCr | |
+16.40% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 17TCr | |
+1.66% | 13TCr |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q2 EPS $2.82